Narcolepsy – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Narcolepsy, a chronic neurological condition, arises from the brain's inability to regulate sleep-wake cycles effectively. Those afflicted with narcolepsy encounter sudden, overpowering urges to sleep at various points during the day, resulting in brief slumber lasting from a few seconds to several minutes. This condition comprises two primary forms: · Type 1 narcolepsy, formerly known as narcolepsy with cataplexy, is diagnosed through low levels of hypocretin (a brain hormone) or the presence of cataplexy. Excessive daytime sleepiness is confirmed through specialized nap tests. · Type 2 narcolepsy, previously called narcolepsy without cataplexy, features excessive daytime sleepiness but typically lacks muscle weakness triggered by emotions. Symptoms are generally less severe, and hypocretin levels remain normal.. Thelansis’s “Narcolepsy Market Outlook, Epidemiology, Competitive Landscape, and...